Last update:

Medical economics news

Oncology & Cancer

Access to a GP can make all the difference in surviving lung cancer—and that is a problem for Māori

Surviving lung cancer in Aotearoa New Zealand could depend on whether you can access a GP—raising questions about equity in the country's health system.

Oncology & Cancer

Clinical cancer research in the US is increasingly dominated by pharmaceutical industry sponsors, study finds

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry sponsored clinical trials compared ...

Health

California may regulate and restrict pharmaceutical brokers

California Gov. Gavin Newsom will soon decide whether the most populous U.S. state will join 25 others in regulating the middlemen known as pharmacy benefit managers, or PBMs, whom many policymakers blame for the soaring ...

Diseases, Conditions, Syndromes

Study finds outbreak detection under-resourced in Asia

A new study led by Duke-NUS Medical School revealed that despite the recent pandemic, outbreak detection efforts remain under-resourced in South and Southeast Asia, with only about half the countries reviewed having integrated ...

Medical economics

Q&A: Donor funding falls short for Africa's digital health

As African countries struggle with overburdened health care systems, limited resources, and an increasing prevalence of chronic diseases such as cancer, digital health innovations are essential.

Obstetrics & gynaecology

Study finds health disparities in preterm births in England

Preterm birth rates are lower than the national average for white women and higher for Black and Asian women, and women living in the most deprived areas, according to a new University of Bristol-led study published in BMC ...

Medical economics

Urban heat islands have a health cost, reveals study

A new study led by EPFL has produced the first cost estimate of the impact that urban heat islands have on human health. The study looked at 85 European cities over the course of three full years, meaning it also took into ...

Diseases, Conditions, Syndromes

NY bill would force insurers to cover copays for Paxlovid

With the life-saving, COVID-fighting drug Paxlovid no longer covered by the federal government, a push is underway in Albany to ensure New Yorkers seeking the medication do not get gouged by pricey co-payments.

Medical economics

What the health care sector was selling at the J.P. Morgan confab

Every year, thousands of bankers, venture capitalists, private equity investors, and other moneybags flock to San Francisco's Union Square to pursue deals. Scores of security guards keep the homeless, the snoops, and the ...